Callaway Hospital Professional Services - Medicare Primary Care in Callaway, NE

Callaway Hospital Professional Services is a medicare enrolled primary clinic (Family Medicine) in Callaway, Nebraska. The current practice location for Callaway Hospital Professional Services is 211 E Kimball St, Callaway, Nebraska. For appointments, you can reach them via phone at (308) 836-2228. The mailing address for Callaway Hospital Professional Services is Po Box 100, Callaway, Nebraska and phone number is (308) 836-2228.

Callaway Hospital Professional Services is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1508979899. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (308) 836-2228.

Contact Information

Callaway Hospital Professional Services
211 E Kimball St
Callaway
NE 68825-2597
(308) 836-2228
(308) 836-2733

Primary Care Clinic Profile

Full NameCallaway Hospital Professional Services
SpecialityFamily Medicine
Location211 E Kimball St, Callaway, Nebraska
Authorized Official Name and PositionBrett D Eggleston (CEO)
Authorized Official Contact3088362228
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Callaway Hospital Professional Services
Po Box 100
Callaway
NE 68825-0100

Ph: (308) 836-2228
Callaway Hospital Professional Services
211 E Kimball St
Callaway
NE 68825-2597

Ph: (308) 836-2228

NPI Details:

NPI Number1508979899
Provider Enumeration Date08/17/2006
Last Update Date01/16/2019

Medicare PECOS Information:

Medicare PECOS PAC ID0143208983
Medicare Enrollment IDO20040714000240

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Callaway Hospital Professional Services such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1508979899NPI-NPPES
10025136800MedicaidNE
DC3835OtherNEMEDICARE RAILROAD
04058OtherNEBCBS OF NEBRASKA
10025136700MedicaidNE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary
363AM0700XPhysician Assistant - Medical (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Callaway Hospital Professional Services acts as a billing entity for following providers:
Provider NameRonald J Sheppard
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1023001724
PECOS PAC ID: 9234116674
Enrollment ID: I20040716001121

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameKenneth L Loper
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1750399903
PECOS PAC ID: 7113985839
Enrollment ID: I20041228000911

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameJulie A Brauer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1437349511
PECOS PAC ID: 6305934282
Enrollment ID: I20071109000269

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameKyle S Myers
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1992142087
PECOS PAC ID: 5597987727
Enrollment ID: I20141104000474

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameTiffany L Svoboda
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1457732224
PECOS PAC ID: 3870800253
Enrollment ID: I20170630001467

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameChelsea M Williams
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1083025803
PECOS PAC ID: 1658590716
Enrollment ID: I20171206001672

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

Provider NameShirley E Osborn
Provider TypePractitioner - Registered Dietitian Or Nutrition Professional
Provider IdentifiersNPI Number: 1093868531
PECOS PAC ID: 8224426598
Enrollment ID: I20211020000105

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more Medical News

› Verified 3 days ago

News Archive

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

Cubist Phase 2 trial for efficacy of CXA-101 in complicated urinary tract infections meets objectives

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

MRI on the nanoscale closer to realty

Magnetic resonance imaging (MRI) on the nanoscale and the ever-elusive quantum computer are among the advancements edging closer toward the realm of possibility, and a new study co-authored by a UC Santa Barbara researcher may give both an extra nudge. The findings appear today in Science Express, an online version of the journal Science.

IPS looks at anticipated impact of free-trade talks on India's generic drug industry

With reports that ongoing negotiations between India and the European Union are expected to end in a free-trade agreement "by the end of August," Inter Press Service examines the concerns among drug manufacturers and exporters over how the agreement might reduce growth in India's generic medicines industry.

Read more News

› Verified 3 days ago


Family Medicine in Callaway, NE

Callaway Medical Clinic Bcbs Pcmh
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 213 E Kimball St, Callaway, NE 68825
Phone: 308-836-2294    Fax: 308-836-2451
Callaway Medical Clinic
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 213 E Kimball St, Callaway, NE 68825
Phone: 308-836-2294    Fax: 308-836-2451

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.